Red Mountain Mining Ltd (PK) (RMTLD) Trades

Arizona Gold & Silver Inc. CEO Mike Stark takes Proactive's Stephen Gunnion through the latest drilling results at the Philadelphia Project in Arizona. Stark highlighted that the company has achieved an 8 for 8 success rate in its infill drilling program, demonstrating strong mineralization both along strike and down dip. Discussing the Rising Fawn target, he noted the consistency of grades between 1.0 to 1.5 grams per tonne, with a 50-meter-wide vein extending beyond 200 meters in depth. This consistency supports the company’s goal of developing a bulk-tonnage, low-grade, heap-leachable resource. Additionally, Stark mentioned that hole 136 could be one of the most promising yet, with visual indicators suggesting high-grade mineralization. He also confirmed that holes 137, 138, and 139 have been completed, with assay results expected soon. Looking ahead, the company remains focused on further drilling and analyzing upcoming assay results, which could influence the next phase of exploration. Stark also noted a strengthened treasury following recent warrant and option exercises, ensuring continued progress at the Philadelphia Project. Stay tuned for more updates on Arizona Gold & Silver’s drilling developments. Don’t forget to like this video, subscribe to Proactive’s YouTube channel, and turn on notifications for future insights. #GoldExploration #MiningStocks #ArizonaGold #SilverMining #DrillingResults #Investing #PreciousMetals #StockMarket #GoldInvesting #PhiladelphiaProject

Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO) executive co-chair and acting CEO Mike Spreadborough and general manager of exploration Kas De Luca talked with Proactive about the company’s upcoming drilling campaign at the Balla Balla Gold Project in Western Australia. Spreadborough outlined that Balla Balla is part of a broader drilling strategy for Novo, which includes projects in New South Wales. He noted that the drilling is expected to begin within weeks, depending on weather conditions. “You'll see four months of news flow as these drilling programs roll through,” he said. De Luca explained that target selection at Balla Balla was guided by geophysical data and historical drilling results. She highlighted the importance of the Sholl Shear Zone, a major regional structure known for gold mineralisation, and the company’s approach in testing its potential. Beyond Balla Balla, Novo is also advancing exploration in New South Wales at Tibooburra and Grafton, aiming for standalone deposits of over one million ounces. With A$12 million in the bank and record-high gold prices, Spreadborough emphasized that Novo is well-positioned for growth. For more updates on Novo Resources and other mining news, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications! #GoldExploration #MiningStocks #NovoResources #GoldInvestment #BallaBalla #GoldMining #DrillingUpdate #ASX #TSX #OTCQX

Sona Nanotech Inc chief medical officer Dr Carman Giacomantonio takes Proactive's Stephen Gunnion through the company’s latest findings related to its targeted hyperthermia therapy (THT), which he described as showing “very enabling immunogenic” effects in recent experiments. The THT platform works by delivering controlled heat to the core of a tumour, triggering a natural cell death response and activating the body's immune system. Giacomantonio explained that this process exposes tumour proteins to immune cells, increasing the chance that they will be recognised and attacked. He noted that “all cancer cells have this kind of evolutionary quality” of resisting cell death, but THT stresses the cells enough to induce it. These latest experiments build on data first shared in December, with increased sample sizes confirming the reproducibility of the results. According to Giacomantonio, tumours treated with saline or checkpoint inhibitors alone continued to grow, while those exposed to THT and the immune modulator PD1 showed complete inhibition or reduction in growth. Looking ahead, he said the company plans to expand testing to demonstrate systemic immune responses, with the goal of treating metastatic cancers by targeting a single tumour site. Visit Proactive's YouTube channel for more company updates. Don’t forget to give this video a like, subscribe to the channel, and enable notifications so you never miss future content. #SonaNanotech #CancerTherapy #TargetedHyperthermia #Immunotherapy #BiotechNews #TumourTreatment #CancerResearch #MedicalInnovation #PD1Inhibitor #MetastaticCancer #HealthcareTech #OncologyBreakthrough

Livium Ltd CEO Simon Linge talked with Proactive about the company’s focus on battery recycling and its potential for growth. Livium’s recycling business is now at break-even and is scaling rapidly to meet increasing demand. The company specialises in recycling large-format batteries for major OEMs, including Hyundai and Volvo. Linge explained that the market for large-format battery recycling is projected to grow from its current size of tens of millions of dollars to approximately $120 million by the end of the decade. He highlighted that government regulations are tightening, pushing the industry towards sustainable disposal methods. Livium has introduced a commercial model where clients pay a service fee for safe battery disposal, with potential rebates from recovered materials. The company is also exploring adjacent opportunities, such as battery storage and diagnostics, and is in discussions with international recyclers looking to collaborate. Additionally, Linge revealed that the company has secured an in-principle government grant of approximately $850,000, supporting its plans to expand across Australia. Watch the full interview to learn more about Livium Ltd’s battery recycling strategy. Don’t forget to like this video, subscribe to our channel, and turn on notifications for more updates from Proactive. #BatteryRecycling #Sustainability #LiviumLtd #EVBatteries #GreenEnergy #BatteryTech #RecyclingInnovation #SustainableFuture #CleanTech #BatteryIndustry